Plain-English translation of NCT06608706 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a therapy called EMDR (Eye Movement Desensitization and Reprocessing) can help people with schizophrenia or related conditions who have experienced trauma. The study will compare people who receive EMDR plus their regular treatment to people who continue with regular treatment alone for 6 months. Researchers want to see if adding this trauma-focused therapy reduces trauma symptoms and improves overall functioning.
Many people with schizophrenia have experienced trauma, but standard treatments don't always address those trauma symptoms. This trial exists to see whether this medication can be safely and effectively used alongside regular schizophrenia care to help heal trauma wounds.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to one of two groups. One group will receive up to 26 sessions of the trauma-focused therapy plus their regular schizophrenia treatment. The other group will continue with their regular treatment alone for 6 months and may receive the therapy later. You will have assessments at the beginning and end to measure changes in your trauma symptoms and overall functioning.
AI-generated summary from trial data · Jun 23, 2026 · Not medical advice
Norway